Conference Coverage

ASCO: New hope for immunotherapy in advanced ovarian cancer

Publish date: June 9, 2015

 

AT 2015 ASCO ANNUAL MEETING

References

pwendling@frontlinemedcom.com

On Twitter @pwendl

Pages

Recommended Reading

PAS: Texting beats phone reminders for HPV vaccine completion
MDedge ObGyn
Mammographic breast density is a strong risk factor for breast cancer
MDedge ObGyn
ACOG: Practice and referral patterns may affect occult uterine sarcoma risk post hysterectomy
MDedge ObGyn
AACR: HPV vaccine may protect some women with prior exposure
MDedge ObGyn
Managing open wounds in ob.gyn.
MDedge ObGyn
ACOG spells out risk assessment for hereditary cancer syndromes
MDedge ObGyn
ACOG: Long-term low-dose vaginal estrogen poses no apparent cancer risk
MDedge ObGyn
ASCO: Precision medicine initiatives take wing
MDedge ObGyn
ASCO: MITO END-2 – Is endometrial cancer starting to catch up?
MDedge ObGyn
ASCO: Ascites may salvage trebananib in recurrent ovarian cancer
MDedge ObGyn